| Creatine supplementation enhances muscle force recovery after eccentrically-induced muscle damage in healthy individuals MB Cooke, E Rybalka, AD Williams, PJ Cribb, A Hayes Journal of the International Society of Sports Nutrition 6, 1-11, 2009 | 184 | 2009 |
| Whey protein isolate attenuates strength decline after eccentrically-induced muscle damage in healthy individuals MB Cooke, E Rybalka, CG Stathis, PJ Cribb, A Hayes Journal of the International Society of Sports Nutrition 7, 1-9, 2010 | 162 | 2010 |
| Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency E Rybalka, CA Timpani, MB Cooke, AD Williams, A Hayes PloS one 9 (12), e115763, 2014 | 140 | 2014 |
| Revisiting the dystrophin-ATP connection: How half a century of research still implicates mitochondrial dysfunction in Duchenne Muscular Dystrophy aetiology CA Timpani, A Hayes, E Rybalka Medical hypotheses 85 (6), 1021-1033, 2015 | 136 | 2015 |
| Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting? JC Sorensen, BD Cheregi, CA Timpani, K Nurgali, A Hayes, E Rybalka Cancer chemotherapy and pharmacology 78, 673-683, 2016 | 75 | 2016 |
| Dimethyl fumarate and its esters: a drug with broad clinical utility? S Kourakis, CA Timpani, JB de Haan, N Gueven, D Fischer, E Rybalka Pharmaceuticals 13 (10), 306, 2020 | 69 | 2020 |
| Idebenone: When an antioxidant is not an antioxidant N Gueven, P Ravishankar, R Eri, E Rybalka Redox biology 38, 101812, 2021 | 62 | 2021 |
| Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better? S Kourakis, CA Timpani, DG Campelj, P Hafner, N Gueven, D Fischer, ... Orphanet Journal of Rare Diseases 16, 1-9, 2021 | 58 | 2021 |
| The failed clinical story of myostatin inhibitors against Duchenne muscular dystrophy: exploring the biology behind the battle E Rybalka, CA Timpani, DA Debruin, RM Bagaric, DG Campelj, A Hayes Cells 9 (12), 2657, 2020 | 47 | 2020 |
| BGP-15 protects against oxaliplatin-induced skeletal myopathy and mitochondrial reactive oxygen species production in mice JC Sorensen, AC Petersen, CA Timpani, DG Campelj, J Cook, AJ Trewin, ... Frontiers in pharmacology 8, 137, 2017 | 44 | 2017 |
| Alamandine reverses hyperhomocysteinemia‐induced vascular dysfunction via PKA‐dependent mechanisms T Qaradakhi, MT Matsoukas, A Hayes, E Rybalka, M Caprnda, ... Cardiovascular therapeutics 35 (6), e12306, 2017 | 36 | 2017 |
| Calming the (Cytokine) storm: dimethyl fumarate as a therapeutic candidate for COVID-19 CA Timpani, E Rybalka Pharmaceuticals 14 (1), 15, 2020 | 35 | 2020 |
| Oxaliplatin‐induced enteric neuronal loss and intestinal dysfunction is prevented by co‐treatment with BGP‐15 RM McQuade, V Stojanovska, R Stavely, C Timpani, AC Petersen, ... British journal of pharmacology 175 (4), 656-677, 2018 | 34 | 2018 |
| Chemotherapy-induced myopathy: the dark side of the cachexia sphere DG Campelj, CA Goodman, E Rybalka Cancers 13 (14), 3615, 2021 | 33 | 2021 |
| Targeting Nrf2 for the treatment of Duchenne muscular dystrophy S Kourakis, CA Timpani, JB de Haan, N Gueven, D Fischer, E Rybalka Redox biology 38, 101803, 2021 | 32 | 2021 |
| Neurotoxicity associated with platinum-based anti-cancer agents: what are the implications of copper transporters? V Stojanovska, R McQuade, E Rybalka, K Nurgali Current medicinal chemistry 24 (15), 1520-1536, 2017 | 31 | 2017 |
| Attempting to compensate for reduced neuronal nitric oxide synthase protein with nitrate supplementation cannot overcome metabolic dysfunction but rather has detrimental … CA Timpani, AJ Trewin, V Stojanovska, A Robinson, CA Goodman, ... Neurotherapeutics 14 (2), 429-446, 2017 | 30 | 2017 |
| Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy CA Timpani, A Hayes, E Rybalka Orphanet journal of rare diseases 12, 1-11, 2017 | 29 | 2017 |
| Metabogenic and nutriceutical approaches to address energy dysregulation and skeletal muscle wasting in duchenne muscular dystrophy E Rybalka, CA Timpani, CG Stathis, A Hayes, MB Cooke Nutrients 7 (12), 9734-9767, 2015 | 29 | 2015 |
| Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy CA Timpani, CA Goodman, CG Stathis, JD White, K Mamchaoui, ... Scientific reports 10 (1), 1125, 2020 | 26 | 2020 |
Cara A TimpaniPostdoctoral Researcher, Victoria UniversityVerified email at vu.edu.au
